Connect Biopharma Holdings (CNTB) Other Non-Current Liabilities (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Other Non-Current Liabilities of $111000.0 for Q1 2026, down 2.63% sequentially from $114000.0 in Q4 2025, and down 82.3% YoY from $627000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Other Non-Current Liabilities for 3 years, with the latest figure at $111000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities fell 82.3% year-over-year to $111000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111000.0 (down 82.3% YoY) and the FY2025 annual result came in at $114000.0, down 81.96% from the prior year.
- Other Non-Current Liabilities slipped to $111000.0 in Q1 2026 per CNTB's latest filing, from $114000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $632000.0 in Q4 2024 and troughed at $111000.0 in Q1 2026.
- A 3-year average of $287333.3 and a median of $120000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities tumbled 81.96% in 2025, then sank 82.3% in 2026.
- Over 3 years, Other Non-Current Liabilities stood at $632000.0 in 2024, then sank by 81.96% to $114000.0 in 2025, then fell by 2.63% to $111000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $111000.0, $114000.0, and $118000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 107,000.00 |
| Mar 31, 2026 | 111,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 627,000.00 |
| Dec 31, 2024 | 632,000.00 |